from NYT Technology
Specialists at the London start-up BenevolentAI helped identify the arthritis drug baricitinib, which is now part of a clinical trial. New York Times Coronavirus (2019-nCoV), Clinical Trials, Artificial Intelligence
By
Sign up here with your email to get Updates from GoWriteUp
ConversionConversion EmoticonEmoticon